Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
Sponsor: AbbVie
Summary
The objective of this study is to assess the safety, tolerability, pharmacokinetics, and immunogenicity of single and multiple doses of ABBV-313 in healthy adult participants.
Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Doses and Multiple Doses of ABBV-313
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2026-06-24
Completion Date
2028-02
Last Updated
2026-09-28
Healthy Volunteers
Yes
Conditions
Interventions
ABBV-313
Injection
Placebo
Injection
ABBV-313
Infusion
Placebo
Infusion
Locations (2)
CenExel Act- Anaheim Clinical Trials /ID# 285208
Anaheim, California, United States
Acpru /Id# 283495
Grayslake, Illinois, United States